GSK, Galderma and Eli Lilly announced refunds for covered entities in notices posted to HRSA's OPA website this month.

GSK, Galderma, Eli Lilly Announce 340B Refunds

August 27, 2026 Shannon Young, Managing Editor 340B Report Views

Three drugmakers recently notified covered entities of changes to their 340B ceiling prices, resulting in refunds. GSK, Galderma and Eli [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!